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Abstract
Objective: due to organ shortage, average waiting time
for a kidney in germany is about 4 years after start of
dialysis. number of kidney grafts recovered can only
be maintained by accepting older and expanded crite-
ria donors. The aim of this study was to analyse the
impact of donor and recipient risk on kidney long-
term function.
Methods: all  deceased  kidney  transplantations  were
considered. We retrospectively studied 332 patients be-
tween 2002 and 2006; divided in 4 groups reflecting
donor and recipient risk.
Results: non-marginal recipients were less likely to re-
ceive a marginal organ (69 of 207, 33%) as compared
to marginal recipients, of whom two-thirds received a
marginal organ (p<0.0001). graft function significant-
ly differed between the groups, but detrimental effect
of marginal recipient status on egfR after 12 months
(-6  ml/min/1.73qm,  95%  cI  -2  to  -9)  was  clearly
smaller than the effect of marginal donor status (-10
ml/min/1.73qm, 95% cI -7 to -14).
Conclusions: as we were able to show expanded crite-
ria donor has a far bigger effect on long-term graft
function  than  the  “extra  risk”  recipient.  although
there have been attempts to define groups of recipi-
ents  who  should  be  offered  Ecd  kidneys  primarily
the discussion is still ongoing.
Key  words: Expanded  criteria  donors,  kidney  trans-
plantation, marginal donors, marginal recipients, out-
come, prognosis
InTRodUcTIon
since  renal  transplantation  is  increasingly  successful,
also older patients and patients with relevant co-mor-
bidities are more frequently accepted on the waiting
list, aggravating the persisting discrepancy between the
number  of  patients  on  the  waiting  list  and  organs
available [1]. Beside this the absolute number of grafts
recovered can only be maintained by accepting older
donors  and  donors  with  characteristics  potentially
causing poorer short- and long-term outcome of kid-
ney transplantation [2]. The quality of the donor or-
gan is one of the strongest parameters for prediction
of  graft  survival  [3,  4].  nevertheless,  it  has  been
shown that recipients of kidneys of marginal donors
or expanded criteria donors have a benefit of extra-life
years compared to wait-listed dialysis patients, despite
decreased long-term graft function [5].
The aim of this study was to analyse the impact of
donor  and  recipient  on  kidney  function  after  trans-
plantation  and  especially  whether  the  converging  of
“extra risk” recipients (i.e. with relevant co-morbidity)
and  marginal  donors  bears  an  additional  risk  com-
pared to other risk constellations.
METHods and sTaTIsTIcs
Definitions: according to the Unos definition an ex-
panded criteria donor was defined as a donor older
than 60 years or older than 50 years with at least two
of the following three criteria: creatinine >1.5 mg/dl,
history of hypertension, cVa as cause of death.
„Extra  risk“  recipients  were  defined  as  recipients
older than 60 years or older than 50 years with at least
one of the following risk factors: coronary heart dis-
ease,  peripheral  arterial  disease  (Pad,  grade  IIa  or
higher), diabetes mellitus.
Study Sample: We studied a registry of consecutive de-
ceased renal transplantations performed in the Univer-
sity Hospital of Essen, germany between 2002 and
2006 (n = 332). There were 138 patients in group 1
(donor  and  recipient  no  extra  risk),  41  in  group  2
(donor non-marginal, extra risk recipient), 69 in group
3 (donor marginal, recipient non extra risk), and 84 in
group 4 (donor marginal, extra risk recipient).
Measurements:  Estimated  glomerular  filtration  rate
(egfR)  was  calculated  using  the  MdRd  formula:
egfR (ml/min/1.73m2) = 186 x crs-1.154 x age-0.203 x
0.742 (if female).
Statistical Analysis: graft loss, delayed graft function
and egfR were compared between the groups by uni-
variate and multivariate statistics. We used a general-
ized linear model to statistically test the influence of
donor  and  recipient  characteristics  on  postoperative
egfR values. This way of analysis accounts for the
dependency among the time points. In case of viola-
tion  of  the  sphericity  assumption,  the  greenhouse-
geisser correction was employed. an interaction term
(donor status; recipient status) was included to answer
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Table 1. Baseline characteristics of the four groups.
group 1:  group 2:  group 3:  group 4:  P-value
donor and donor non- donor  donor and 
recipient  marginal,  marginal,  recipient 
non- recipient recipient  marginal
marginal marginal non-
marginal
no. of patients 138 41 69 84 -
females (%) 55 (39.9%) 20 (48.8%) 30 (43.5%) 28 (33.3%) 0.359
Recipient age (years) 42.7 ﾱ 10.4 61.8 ﾱ 5.0 42.7 ﾱ 10.1 64.5 ﾱ 5.1 <0.001
Recipient body mass index (kg/m2) 24.7 ﾱ 4.6 25.5 ﾱ 4.0 23.9 ﾱ 3.5 25.4 ﾱ 3.8 0.102
Recipient comorbidity
arterial hypertension 14 (10%) 5 (12%) 9 (13%) 4 (5%) 0.325
arteriosclerotic disease 15 (11%) 19 (46%) 7 (10%) 26 (31%) <0.001
Heart insufficiency 10 (7%) 4 (10%) 2 (3%) 8 (10%) 0.387
diabetes mellitus 11 (8%) 14 (34%) 3 (4%) 15 (18%) <0.001
Thyroid disease 9 (7%) 2 (5%) 7 (11%) 9 (11%) 0.528
secondary hyperparathyreoidism 91 (66%) 24 (60%) 44 (66%) 54 (68%) 0.907
Tertiary hyperparathyreoidism 8 (6%) 3 (8%) 4 (6%) 2 (3%) 0.907
Hypercholesterolemia 18 (13%) 8 (20%) 14 (20%) 33 (40%) <0.001
chronic obstructive lung disease 8 (6%) 2 (5%) 2 (3%) 5 (6%) 0.808
duration of dialysis (months) 72 (42) 67 (36) 86 (55) 63 (35) 0.007
first transplantation 101 (73%) 34 (83%) 50 (73%) 66 (79%) 0.802
Hla-dR mismatches (0/1/2) 46 (33%) 14 (34%) 26 (38%) 18 (21%)
60 (43%) 15 (37%) 28 (41%) 32 (38%) 0.083
32 (23%) 12 (29%) 15 (22%) 34 (41%)
same gender transplantation 60 (44%) 21 (51%) 35 (53%) 47 (56%) 0.571
Table 2. clinical results in the four groups.
group 1:  group 2:  group 3:  group 4:  P-value
donor and  donor non- donor donor and 
recipient  marginal,  marginal,  recipient
non- recipient recipient marginal
marginal marginal non-
marginal
no. of patients 138 41 69 84 -
duration of surgery (minutes) 159 ﾱ 63 164 ﾱ 63 153 ﾱ 41 173 ﾱ 71 0.358
Immunosuppression
Mycophenolate mofetil (cell cept) 101 (73%) 24 (59%) 44 (64%) 53 (63%) 0.203
Tacrolimus 86 (62%) 22 (54%) 37 (54%) 49 (58%) 0.593
cyclosporin a 44 (32%) 18 (44%) 25 (36%) 30 (36%) 0.559
sirolimus 5 (4%) 1 (2%) 11 (16%) 4 (5%) 0.003
Intensive care stay donor (days) 6.2 ﾱ 5.7 6.9 ﾱ 6.6 6.1 ﾱ 6.0 3.5 ﾱ 3.2 0.001ﾧ
Hospital stay recipient (days) 18.0 ﾱ 14.0 18.9 ﾱ 14.2 15.7 ﾱ 11.6 17.7 ﾱ 19.5 0.699
any complication * 48 (36%) 20 (49%) 36 (52%) 36 (43%) 0.151
Rejection 38 (28%) 2 (5%) 27 (39%) 26 (31%) 0.001
Primary non-function requiring dialysis 50 (38%) 11 (27%) 20 (29%) 32 (39%) 0.355
loss of graft 8 (6%) 2 (5%) 7 (10%) 8 (10%) 0.539
death 3 (2%) 2 (5%) 1 (1%) 6 (7%) 0.176
* except urinary tract infection;  ﾧ additional nonparametric testing yielded a P = 0.001 by Kruskal-Wallis test
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donors are especially detrimental when implanted in
marginal recipients. To compare among the groups, we
used  standard  statistical  methodology,  including
anoVa and chi-square testing. a p-value of less than
0.05 was used to define significance.
REsUlTs
about 75% of the 332 patients received their first kid-
ney  transplantation.  The  average  duration  of  pre-
transplant dialysis was 6 years. as expected, marginal
recipients were significantly older and more likely to
suffer from co-morbidities (Table 1). about half of all
patients received their graft from a donor having the
same gender. non-marginal recipients were less likely
to receive a marginal organ (69 of 207, 33%) as com-
pared to marginal recipients, of whom two thirds re-
ceived a marginal organ (p<0.0001).
Median  IcU  stay  of  the  donor  was  4  days  (in-
terquartile range 2 to 8) and was significantly shorter
in group 4. The rate of delayed graft function defined
by necessity of dialysis in the first week after trans-
plantation was 35%, but without difference among the
groups. delayed graft function was slightly more likely
to be developed in patients who were on dialysis prior
to  transplantation  for  a  longer  duration  (78  vs.  69
months, p = 0.078) (Table 2).
graft  function  significantly  differed  between  the
four groups, but the detrimental effect of marginal re-
cipient status on egfR after 12 months (-6 ml/min/
1.73qm, 95% cI -2 to -9) was clearly smaller than the
effect of marginal donor status (-10 ml/min/1.73qm,
95% cI -7 to -14) (fig. 1). In multivariate analysis,
only  marginal  donor  status  significantly  (p<0.001) 
affected graft function after 1 and 12 months, Table 3.
However, there was a tendency (p = 0.072) towards
higher  egfR  after  1  year  in  patients  without 
pre-transplant arterial hypertension (45 ﾱ 16) as op-
posed to those with hypertensive disease (41 ﾱ 14).
Rates of death after one year in the extra risk recipi-
ents  were  higher  compared  to  the  other  recipients
(6.4%  vs.  1.9%)  but  without  reaching  significance 
(p = 0.07).
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Table 3. Results of multivariate regression analyses.
egfR at 1 week egfR at 1 month egfR at 12 months
Marginal donor 0.054 <0.001 <0.001
Marginal recipient 0.852 0.611 0.153
Hla mismatches 0.103 0.685 0.983
duration of dialysis 0.416 0.658 0.571
Fig. 1. Recipient egfR (in ml/min/1.73m2) at transplantation, and after 1, 4, and 52 weeks in the four groups.
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clinical reality in kidney transplantation is determined
by nearly stable numbers of organ donors with an in-
crement  of  the  relative  number  of  expanded  criteria
donors. The influence of the quality of donor organs
for long-term graft survival has been demonstrated. al-
though just about 15% of all patients on dialysis are ac-
tually on the waiting lists in the Eurotransplant region,
which means that a large number of patients do not
qualify for kidney transplantation because of their med-
ical status, the number of older recipients and recipi-
ents with relevant co-morbidities seems to increase. We
tried to define an extra risk recipient by combination of
age and distinct co-morbidities like diabetes, coronary
heart disease and Pad, since these influence mortality
after kidney transplantation as well as on dialysis. The
one year patient survival rate of Ecd kidney recipients
was 95.4% thus comparable to Unos data with one
year  graft  survival  rates  of  90%  nearly  identical  to
Unos data [6]. The differences in outcome concerning
graft and patient survival compared to non- Ecd kid-
ney recipients were not significant in this ana  lysis, but
are consistent with Unos data. nevertheless, results of
Ecd and standard donor kidney transplantation cannot
be directly compared because age and co-morbidities
are not equally distributed between Ecd and standard
recipients.  This  analysis  stratifies  outcome  related  to
donor and recipient risk. as we were able to show the
expanded criteria donor has a far bigger effect on long-
term graft function than the “extra risk” recipient. al-
though there have been attempts to define groups of
recipients who should be offered Ecd kidneys primari-
ly the discussion is still ongoing. In a recent review it
was concluded that just patients younger than 40 years
scheduled for re-transplantation should not be offered
Ecd kidneys, since survival for patients older than 40
years receiving an Ecd kidney is better than remaining
on dialysis [7]. schold et al. showed that older patients
(65+) had a longer life expectancy when transplanted
with  an  Ecd  kidney  within  2  years  of  EsRd  onset
compared with waiting on a standard kidney [8]. The
duration of pre-transplant dialysis has a significant im-
pact on outcome after trans  plantation especially includ-
ing analysis of larger databases which emphasize early
transplantation of marginal recipients because of high-
er risk of mortality on dialysis [9-12].since we could
show that the efficacy of transplantation of marginal
kidneys is similar in younger and non-co-morbid versus
older  co-morbid  patients,  we  can  conclude  that  the
margins  of  safety  are  usually  not  to  close,  when  an
Ecd kidney is transplanted to an extra risk recipient.
Therefore,  the  advantages  of  shorter  waiting  times
should be taken actively. our results and recent reviews
suggest  that  programs  conveying  short  waiting  times
like the Eurotransplant senior program should be ex-
tended from recipients older than 65 years to recipients
older than 60 years or even younger [13-15].
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